UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2011, Volume 140, Issue 4, pp. 1120 - 1125.e12
Journal Article
Journal of hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 1, pp. 155 - 168
Gastroenterology and Hepatology | Gallstones | Liver cancer | Bile acids | Fatty liver disease | Cholestasis | Liver regeneration | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Animals | Carrier Proteins - metabolism | Cholestasis - metabolism | Membrane Glycoproteins - metabolism | Humans | Liver - metabolism | Bile Acids and Salts - metabolism | Liver Diseases - metabolism | Liver Regeneration - physiology | Receptors, Cytoplasmic and Nuclear - metabolism | Drug resistance in microorganisms | Corticosteroids | Glucagon | Calcifediol | Ursodiol | Deoxycholic acid | Epidermal growth factor | Vitamin D | Physiological aspects | Fibroblast growth factors | Alfacalcidol | Index Medicus | IBABP (FABP6, ILBP), intestinal bile acid-binding protein, fatty acid-binding protein 6 | PFIC, progressive familial intrahepatic cholestasis | TNFα, tumor necrosis factor α | 3 (human) | SRC2, p160 steroid receptor coactivator | NAFLD, non-alcoholic fatty liver disease | BA, bile acid | bile acid receptor | 8, cholesterol efflux pump, ATP-binding cassette, subfamily G, member 5 | UDCA, ursodeoxycholic acid | LRH-1 (NR5A2), liver receptor homolog-1 | LCA, lithocholic acid | LXRα (NR1H3), liver X receptor alpha | PPARγ (NR1C3), peroxisome proliferator-activated receptor gamma | OSTαβ, organic solute transporter alpha | ABCG5 | AMPK, AMP activated protein kinase | NASH, non-alcoholic steatohepatitis | SHP (NR0B2), short heterodimer partner | OATP1A2 (SLCO1A2, OATP1, OATP-A, SLC21A3), solute carrier organic anion transporter family, member 1A2 | EGFR, epidermal growth factor receptor | IL6, interleukin 6 | TGR5, G protein-coupled bile acid receptor | PH, partial hepatectomy | AE2, anion exchanger 2 | PSC, primary sclerosing cholangitis | OATP1B1 (SLCO1B1, OATP2, OATP-C, SLC21A6), solute carrier organic anion transporter family, member 1B1 | RARα (NR1B1), retinoic acid receptor alpha | GLP-1, glucagon like peptide 1 | VDR (NR1I1), vitamin D receptor. Please note that for the convenience of better readability and clarity, abbreviations for transporters and nuclear receptors were capitalized throughout this article when symbols were identical for human and rodents | MRP2 (ABCC2), multidrug resistance-associated protein 2, ATP-binding cassette, subfamily C, member 2 | NTCP (SLC10A1), sodium | CAR (NR1I3), constitutive androstane receptor | taurocholate cotransporting polypeptide, solute carrier family 10, member 1 | PPARα (NR1C1), peroxisome proliferator-activated receptor alpha | Review | GR (NR3C1), glucocorticoid receptor | Bile acids, Cholestasis, Fatty liver disease, Gallstones, Liver regeneration, Liver cancer | 19, fibroblast growth factor 15 | Mdr2 | ICP, intrahepatic cholestasis of pregnancy | BRIC, benign recurrent intrahepatic cholestasis | OATP1B3 (SLCO1B3, OATP8, SLC21A8), solute carrier organic anion transporter family, member 1B3 | MRP3 (ABCC3), multidrug resistance-associated protein 3, ATP-binding cassette, subfamily C, member 3 | beta | MDR1 (ABCB1), p-glycoprotein, ATP-binding cassette, subfamily B, member 1 | norUDCA, norursodeoxycholic acid | 6-ECDCA, 6-ethylchenodeoxycholic acid | FXR (NR1H4), farnesoid X receptor | BCRP (ABCG2), breast cancer resistance protein, ATP-binding cassette, subfamily G, member 2 | HNF4α (NR2A1), hepatocyte nuclear factor 4 alpha | PBC, primary biliary cirrhosis | MDR3 (ABCB4), multidrug resistance protein 2 (rodents) | HNF1α, hepatocyte nuclear factor 1 alpha | NR, nuclear receptor | FGF15 | RXRα (NR2B1), retinoid X receptor alpha | PXR (NR1I2), pregnane X receptor | BSEP (ABCB11), bile salt export pump | HCC, hepatocellular carcinoma | MRP4 (ABCC4), multidrug resistance-associated protein 4, ATP-binding cassette, subfamily C, member 4 | TPN, total parenteral nutrition
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 04/2017, Volume 65, Issue 4, pp. 1393 - 1404
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Liver Circulation - physiology | Severity of Illness Index | Signal Transduction | Humans | Bile Acids and Salts - metabolism | Treatment Outcome | Cholestasis - physiopathology | Animals | Taurocholic Acid - administration & dosage | Biological Transport - drug effects | Cholestasis - drug therapy | Cohort Studies | Disease Models, Animal | Liver diseases | Bile | Index Medicus
Journal Article
Baillière's best practice & research. Clinical gastroenterology, ISSN 1521-6918, 2011, Volume 25, Issue 6, pp. 727 - 739
Gastroenterology and Hepatology | Inflammatory bowel diseases | Primary sclerosing cholangitis (PSC) | Immunology | Pathogenesis | Aetiology | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Animals | Major Histocompatibility Complex - genetics | Cholangitis, Sclerosing - immunology | Bile - chemistry | Humans | Inflammatory Bowel Diseases - immunology | Cholangitis, Sclerosing - genetics | Cholangitis, Sclerosing - complications | Mice | Inflammatory Bowel Diseases - complications | Disease Models, Animal | Autoimmunity | Autoantibodies | Histocompatibility antigens | Liver diseases | Analysis | Gastrointestinal diseases | HLA histocompatibility antigens | Index Medicus
Journal Article
Journal of hepatology, ISSN 0168-8278, 09/2017, Volume 67, Issue 3, pp. 549 - 558
Bile acid treatment | Alkaline phosphatase | Side chain-shortened bile acids | Sclerosing cholangitis | Cholehepatic shunting | Cholestasis | Ursodeoxycholic acid | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Cholangitis, Sclerosing - drug therapy | Double-Blind Method | Ursodeoxycholic Acid - analogs & derivatives | Humans | Middle Aged | Male | Ursodeoxycholic Acid - adverse effects | Ursodeoxycholic Acid - therapeutic use | Dose-Response Relationship, Drug | Adult | Female | Cholestasis - drug therapy | Alkaline Phosphatase - blood | Inflammation | Bile duct | Cholangitis | Bile | Gallbladder diseases | Clinical trials | Pruritus | Patients | Index Medicus | Klinisk medicin | p120 | primary biliary-cirrhosis | inflammation | v11 | bile-acids | azouilleres o | knockout mice | survival | controlled-trial | 1990 | Clinical Medicine | liver fibrosis | alkaline-phosphatase | journal of hepatology | quality-of-life | dose ursodeoxycholic acid | Medicin och hälsovetenskap
Journal Article